Cost of Illness Associated With Influenza in the UK

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Influenza

Treatments: Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01521416

116313

Details and patient eligibility

About

The objective of this study is to describe the burden associated with influenza in the UK, from both primary and secondary care perspectives, and to stratify the burden by the annual degree of mismatch between predicted and actual virus strains.

Full description

This is a retrospective, cross sectional, exploratory, observational study using database analysis and therefore there is no patient or user group involvement.

Enrollment: 1 patient

Sex: All

Ages: 5 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female patients coded within the database as having acute respiratory events that could be related to an infection between 2001 and 2009.
• Patients must have a minimum of 14 days observation before and after the index event to permit the capturing of complications attributable to influenza.

Exclusion criteria

Not Applicable

Trial design

1 participants in 1 patient group

Cohort Group

Treatment:

Other: Data collection